Interferon interplay helps tissue cells to cope with SARS-coronavirus infection

Virulence

Volumn 1, Issue 4, 2010, Pages 273-275

  Kuri, Thomas ^a   Weber, Friedemann ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Interferon antagonism; Interferon induction; Interferon priming; Plasmacytoid dendritic cells; SARS

Indexed keywords

INTERFERON;

ARTICLE; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; INNATE IMMUNITY; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN SECRETION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; UBIQUITINATION;

SARS CORONAVIRUS;

EID: 77955042448     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.4.11465     Document Type: Article

References (38)

1. WHO. Summary table of SARS cases by country, 1 November 2002-26 September 2003. http://wwwwhoint/csr/sars/country/table2004_04_21/en/indexhtml 2004.
2. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
3. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-66.
4. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362:263-70.
5. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319-25.
6. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA 2005; 102:14040-5.
7. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310:676-9.
8. Pfefferle S, Oppong S, Drexler JF, Gloza-Rausch F, Ipsen A, Seebens A, et al. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerging infectious diseases 2009; 15:1377-84.
9. Haller O, Kochs G, Weber F. Interferon, Mx and viral countermeasures. Cytokine Growth Factor Rev 2007; 18:425-33.
10. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778-809.
11. Pichlmair A, Reise Sousa C. Innate recognition of viruses. Immunity 2007; 27:370-83.
12. Yoneyama M, Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008; 29:178-81.
13. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007; 282:15325-9.
14. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet 2003; 362:293-4.
15. Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, et al. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004; 10:290-3.
16. Spiegel M, Pichlmair A, Mühlberger E, Haller O, Weber F. The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA. J Clinical Virol 2004; 30:211-3.
17. Stroher U, DiCaro A, Li Y, Strong JE, Aoki F, Plummer F, et al. Severe acute respiratory syndromerelated coronavirus is inhibited by interferon-alpha. J Infect Dis 2004; 189:1164-7.
18. Frieman M, Heise M, Baric R. SARS coronavirus and innate immunity. Virus Res 2007.
19. Thiel V, Weber F. Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev 2008; 19:121-32.
20. Stertz S, Reichelt M, Spiegel M, Kuri T, Martinez-Sobrido L, Garcia-Sastre A, et al. The intracellular sites of early replication and budding of SARScoronavirus. Virology 2007; 361:304-15.
21. Knoops K, Kikkert M, Worm SH, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, et al. SARScoronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 2008; 6:226.
22. Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 2007; 361:18-26.
23. Spiegel M, Pichlmair A, Martinez-Sobrido L, Cros J, Garcia-Sastre A, Haller O, Weber F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 2005; 79:2079-86.
24. Devaraj SG, Wang N, Chen Z, Chen Z, Tseng M, Barretto N, et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 2007; 282:32208-21.
25. Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 2007; 81:548-57.
26. Siu KL, Kok KH, Ng MH, Poon VK, Yuen KY, Zheng BJ, Jin DY. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3. TANK.TBK1/IKKepsilon complex. J Biol Chem 2009; 284:16202-9.
27. Kamitani W, Narayanan K, Huang C, Lokugamage K, Ikegami T, Ito N, et al. Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci USA 2006; 103:12885-90.
28. Wathelet MG, Orr M, Frieman MB, Baric RS. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 2007; 81:11620-33.
29. Barchet W, Cella M, Colonna M. Plasmacytoid dendritic cells-virus experts of innate immunity. Seminars in immunology 2005; 17:253-61.
30. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009; 227:75-86.
31. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007; 109:1131-7.
32. Erlandsson L, Blumenthal R, Eloranta ML, Engel H, Alm G, Weiss S, Leanderson T. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr Biol 1998; 8:223-6.
33. Phipps-Yonas H, Seto J, Sealfon SC, Moran TM, Fernandez-Sesma A. Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog 2008; 4:1000193.
34. Stewart WE, 2nd, Gosser LB, Lockart RZ Jr. Priming: a nonantiviral function of interferon. J Virol 1971; 7:792-801.
35. Kuri T, Zhang X, Habjan M, Martinez-Sobrido L, Garcia-Sastre A, Yuan Z, Weber F. Interferon priming enables cells to partially overturn the SARSCoronavirus-induced block in innate immune activation. J Gen Virol 2009; 90:2686-94.
36. He B. Viruses, endoplasmic reticulum stress and interferon responses. Cell Death Differ 2006; 13:393-403.
37. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (SARS) patients. J Virol 2007; 81:8692-706.
38. de Lang A, Baas T, Teal T, Leijten LM, Rain B, Osterhaus AD, et al. Functional Genomics Highlights Differential Induction of Antiviral Pathways in the Lungs of SARS-CoV Infected Macaques. PLoS Pathogens 2007; 3:112.